What is the current market size?

The Monofilament Polyamide Suture market size reached USD 1.1 billion in 2024, driven by surgical demand and product innovation.

What is the expected growth rate?

The market is projected to grow at a CAGR of 6.2% from 2025 to 2032, with the future outlook bolstered by advanced wound care trends.

What are the key growth drivers?

Key drivers include rising minimally invasive surgeries, growing geriatric populations, and the need for suture materials with superior strength and flexibility.

What challenges does the market face?

Challenges include stringent regulatory approvals, cost sensitivity in emerging economies, and competition from absorbable suture alternatives.

Which regions lead the market?

North America dominates due to advanced healthcare infrastructure, while Asia-Pacific shows fastest growth from rising surgical volumes.

Who are the top companies?

Leading players include Ethicon, Medtronic, B. Braun, and Johnson & Johnson, which leverage R&D and strategic partnerships to maintain market share.

What future opportunities exist?

Opportunities lie in expanding applications in cosmetic surgery, emerging markets, and innovations in biocompatible suture materials.

How does technology impact the market?

Advances in polymer science and laser-based manufacturing enhance suture durability, reducing infection risks and improving patient outcomes.

What is the regulatory landscape?

Regulatory bodies like the FDA and EU MDR enforce strict quality standards, ensuring safety and efficacy while increasing compliance costs for manufacturers.

How does the market size compare globally?

The Monofilament Polyamide Suture market size in Europe is second to North America but is expected to grow steadily due to increasing healthcare investments.

Monofilament Polyamide Suture Market Growth Drivers & Forecast 2033

Monofilament Polyamide Suture by Application (Hospital, Clinic, Others), by Types (Colorless Polyamide Suture, Dyeing Polyamide Suture), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Monofilament Polyamide Suture Market Overview

The Monofilament Polyamide Suture market refers to the global demand for synthetic, single-strand surgical sutures made from polyamide (nylon) polymers, widely used in general and specialized surgical procedures due to their strength, flexibility, and resistance to infection. As a critical component of the surgical suture industry, this market is pivotal in addressing the growing need for reliable, non-absorbable sutures in high-volume medical procedures. The Monofilament Polyamide Suture market size is projected to reach $1.5 billion by 2033, reflecting a CAGR of 6.8% from 2026 to 2033, driven by macro trends such as the rise in minimally invasive surgeries and advancements in material technology.

Loading chart…

The market is shaped by technological innovation in antimicrobial coatings and regulatory shifts prioritizing infection control in surgical devices. North America remains the largest regional market, fueled by advanced healthcare infrastructure and high adoption of premium sutures. Meanwhile, Asia-Pacific is the fastest-growing region, driven by expanding surgical volumes and cost-sensitive healthcare reforms. The segment-stacked chart above highlights the dominance of General Surgery applications, which accounted for over 42% of the market in 2021, while Orthopedic applications face declining share due to the rise of absorbable alternatives. Strategic partnerships between raw material suppliers and manufacturers will be critical to mitigate supply-chain disruptions and meet rising global demand.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Medtronic; B. Braun; Corza Medical; Demetech Corporation; Unimed; Covidien; Hu-Friedy Mfg; Peters Surgical; DemeTech; Kono Manufacturing; Dolphin; Assut Medical Sarl; Teleflex; Lotus Surgicals; Luxsutures; Advanced MedTech Solutions; SERAG-WIESSNER
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Monofilament Polyamide Suture market is expanding due to rising demand for minimally invasive surgeries, which favor sutures with high tensile strength and reduced tissue reactivity. Innovations in polymer engineering have enhanced suture durability, aligning with clinical requirements for faster healing and lower infection risks.

Growing adoption of Monofilament Polyamide Suture market size in orthopedic and cardiovascular procedures is driving growth. These sutures offer superior knot security and flexibility, meeting the precision demands of complex surgeries while reducing the need for repeated interventions.

Restraints2 items

High production costs associated with polyamide materials limit market accessibility, particularly for low-income regions. The energy-intensive manufacturing process increases pricing pressures, deterring adoption in price-sensitive healthcare systems.

Stringent regulatory requirements for medical devices, including FDA and ISO 13485 compliance, delay product launches and raise R&D expenses. Non-compliance risks and costly recalls further hinder market expansion.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present untapped potential due to improving healthcare infrastructure and rising surgical volumes. Strategic partnerships with local distributors can accelerate Monofilament Polyamide Suture market penetration.

Development of bioabsorbable polyamide variants offers a competitive edge. These products cater to the growing preference for sutures that eliminate the need for removal, enhancing patient comfort and reducing long-term healthcare costs.

Challenges2 items

Intense competition among key players is triggering price wars, compressing profit margins. Companies must balance innovation with cost efficiency to maintain market share.

Supply chain vulnerabilities, exacerbated by geopolitical tensions and raw material scarcity, disrupt production timelines. Diversifying suppliers and adopting agile manufacturing strategies are critical to mitigating these risks.

Market Segmentation

Loading chart…

The Monofilament Polyamide Suture market is segmented by application, reflecting diverse surgical and medical requirements. Key subcategories include Cardiovascular Surgery, General Surgery, and Orthopedic Procedures. Cardiovascular applications dominate, driven by high procedural volumes and the need for sutures with optimal tensile strength and biocompatibility. General Surgery accounts for a significant share, particularly in abdominal and thoracic procedures, where minimally invasive techniques favor fine-gauge monofilament sutures. Orthopedic use is growing due to increasing demand for sports medicine and joint repair surgeries. These segments collectively define the market taxonomy, with Cardiovascular contributing ~40% of the market, General Surgery ~35%, and Orthopedic ~25%, underscoring the application-specific demand dynamics shaping the Monofilament Polyamide Suture segmentation.

Monofilament Polyamide Suture types are categorized into Absorbable and Non-Absorbable subtypes, each addressing distinct clinical requirements. Absorbable variants, such as polydioxanone (PDS) and poliglecaprone 25 (PG), are utilized in internal tissues requiring temporary support, with degradation rates tailored to healing timelines. Non-Absorbable types, including polyamide (Nylon) and polypropylene (Prolene), are preferred for high-stress applications like vascular anastomoses, where long-term structural integrity is critical. The absorbable segment is expanding due to regulatory approvals for synthetic polymers, while non-absorbable sutures maintain a stable market share in high-precision procedures. This Monofilament Polyamide Suture segmentation highlights the interplay between material innovation and procedural needs, with Absorbable and Non-Absorbable subtypes collectively accounting for ~60% and ~40% of the market, respectively.

Monofilament Polyamide Suture Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Colorless Polyamide Suture

Dyeing Polyamide Suture

Regional Insights

Loading chart…

The Monofilament Polyamide Suture market is driven by regional disparities in healthcare infrastructure, regulatory frameworks, and demographic trends. North America leads with a 35% share, fueled by advanced surgical adoption, robust R&D investments, and favorable reimbursement policies. The region’s aging population and high prevalence of chronic diseases further accelerate demand for precision sutures.

Europe (25% share) maintains maturity through stringent regulatory alignment (EU MDR) and widespread adoption of minimally invasive surgeries. Germany and France dominate due to their established healthcare ecosystems and partnerships with global manufacturers.

The Asia Pacific region emerges as the fastest-growing market, projected to capture 20% by 2028. Urbanization, rising disposable incomes, and government initiatives (e.g., India’s PLI scheme) are closing infrastructure gaps. Japan’s aging population and China’s expanding private healthcare sector also drive adoption.

Latin America (15%) and the Middle East & Africa (5%) show potential amid improving healthcare access. Brazil’s public-private partnerships and UAE’s medical tourism investments are key growth levers. However, economic volatility and underdeveloped reimbursement systems remain barriers.

Key Regional Drivers5 items

North America: Advanced healthcare infrastructure, high R&D spending, aging demographics

Europe: EU regulatory compliance, high surgeon expertise, mature MIVS adoption

Asia Pacific: Urbanization, government healthcare reforms, rising middle-class disposable income

Latin America: Public-private healthcare collaborations, growing surgical volumes

Middle East & Africa: Private-sector infrastructure investments, medical tourism growth

The Monofilament Polyamide Suture regional forecast underscores Asia Pacific’s ascent, while North America retains dominance. Stakeholders must prioritize innovation, regulatory alignment, and ecosystem partnerships to capitalize on these dynamics.

Competitive Landscape

The Monofilament Polyamide Suture competitive landscape is moderately consolidated, with a mix of global and regional players. Major manufacturers such as Johnson & Johnson and Medtronic dominate through extensive product portfolios and established distribution networks, while niche firms like Corza Medical and Demetech Corporation focus on specialized applications. Key competitive differentiators include regulatory approvals (e.g., FDA/EU MDR compliance), pricing strategies tailored to regional healthcare spending, and innovation in biocompatibility features. Market participants also leverage partnerships with OEMs and surgical device providers to strengthen market access.

Strategies emphasize R&D for absorbable variants, localization through regional manufacturing hubs, and strategic partnerships to mitigate supply chain risks. Differentiation is driven by technology (e.g., precision-coated sutures) and service models (e.g., customized sterilization options). A critical challenge is balancing compliance costs amid evolving regulatory standards, particularly in emerging markets. Companies like B. Braun and Teleflex prioritize cost-optimization frameworks to counter margin pressures, while smaller players such as Peters Surgical and Advanced MedTech Solutions target underserved segments through flexible customization.

Johnson & Johnson: Expansion in emerging markets via surgical equipment bundling

Medtronic: R&D investment in absorbable polyamide variants for orthopedic applications

B. Braun: Vertical integration to stabilize raw material procurement costs

Corza Medical: OEM partnerships for specialty sutures in reconstructive surgery

Teleflex: Premium pricing tied to proprietary anti-microbial coating technology

Demetech Corporation: Local manufacturing in Asia-Pacific for cost-sensitive clients

Key Monofilament Polyamide Suture Companies18 items

Johnson & Johnson

Medtronic

B. Braun

Corza Medical

Demetech Corporation

Unimed

Covidien

Hu-Friedy Mfg

Peters Surgical

DemeTech

Kono Manufacturing

Dolphin

Assut Medical Sarl

Teleflex

Lotus Surgicals

Luxsutures

Advanced MedTech Solutions

SERAG-WIESSNER

Market Ecosystem

The Monofilament Polyamide Suture ecosystem spans upstream raw material sourcing, midstream manufacturing, and downstream delivery. Value creation begins with polymer suppliers, flows through production of sterilized surgical sutures, and terminates in end-user applications. A value chain analysis highlights dependencies between technological innovation, regulatory compliance, and healthcare infrastructure.

Raw material suppliers — supply nylon 6/6 polymer and additives for filament production

Technology providers — license extrusion and coating equipment for suture manufacturing

OEM manufacturers — produce monofilament sutures via specialized polymer processing

Distributors — manage logistics to hospitals, clinics, and surgical centers

Regulators — enforce compliance with ISO 13485 and FDA Class II medical device standards

End users — hospitals and ambulatory surgical centers using sutures for wound closure

Service providers — offer sterilization, packaging, and post-market surveillance solutions

Control points reside with regulators through certification requirements and manufacturers through proprietary production techniques. Dependency risks include raw material supply chain disruptions and compliance bottlenecks. High certification switching costs between manufacturers shape long-term partnerships, while interoperability requirements for surgical kits influence distributor capabilities.

Recent Industry Insights

The Monofilament Polyamide Suture industry trends reveal a dynamic landscape shaped by innovation and strategic moves. Over the past 18 months, partnerships have strengthened global supply chains, with key players collaborating to enhance distribution in Asia-Pacific markets. Meanwhile, mergers & acquisitions have accelerated, as larger med-tech firms acquire niche sutures companies to expand their non-absorbable product portfolios. Notably, product/technology launches dominated 2023, including advanced coatings to reduce infection risks and improved knot security in robotic surgeries. Regulatory shifts, such as updated FDA guidelines on biocompatibility testing, have also driven R&D investments. Enterprise demand has pivoted toward sustainable manufacturing processes, while funding rounds—like a $50M Series B by a European startup—have fueled next-gen suture development. These trends underscore a forward-looking industry prioritizing precision, compliance, and global accessibility.

Analyst Overview

The Monofilament Polyamide Suture market remains a highly attractive segment within the global medical devices industry, driven by rising demand for minimally invasive surgeries and robust growth in emerging markets. Competitive intensity is moderate, characterized by a mix of established players and niche innovators, with strategic partnerships and product differentiation key to gaining market share. The long-term outlook is optimistic, underpinned by aging populations and increasing surgical volumes, particularly in Asia-Pacific regions. The innovation landscape is evolving rapidly, with advancements in bioabsorbable variants and antimicrobial coatings enhancing product performance. Demand–supply balance is currently stable, though raw material price volatility poses potential disruptions. Decision-makers must remain vigilant about key risk factors, including stringent regulatory requirements, pricing pressures, and competition from alternative suture technologies. Overall, the Monofilament Polyamide Suture market outlook suggests sustained growth through 2030, provided stakeholders prioritize R&D and supply chain resilience.

11 items

1. Executive Summary

2. Monofilament Polyamide Suture Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Monofilament Polyamide Suture Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Monofilament Polyamide Suture Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Monofilament Polyamide Suture Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Colorless Polyamide Suture

6.2.2. Dyeing Polyamide Suture

6.3. Global Monofilament Polyamide Suture Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Monofilament Polyamide Suture Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Monofilament Polyamide Suture Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Monofilament Polyamide Suture Market Competition by Key Manufacturers

8.1. Global Monofilament Polyamide Suture Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Monofilament Polyamide Suture: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Johnson & Johnson

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Medtronic

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. B. Braun

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Corza Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Demetech Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Unimed

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Covidien

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Hu-Friedy Mfg

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Peters Surgical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. DemeTech

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Kono Manufacturing

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Dolphin

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Assut Medical Sarl

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Teleflex

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Lotus Surgicals

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Luxsutures

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Advanced MedTech Solutions

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. SERAG-WIESSNER

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Monofilament Polyamide Suture Market

Figure 4: Global Monofilament Polyamide Suture Market: Drivers

Figure 5: Global Monofilament Polyamide Suture Market: Challenges

Figure 6: Global Monofilament Polyamide Suture Market: Trends

Figure 7: Global Monofilament Polyamide Suture Market: Opportunity

Figure 8: Global Monofilament Polyamide Suture Market: Restraint

Figure 9: Global Monofilament Polyamide Suture Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Monofilament Polyamide Suture Market Value (USD Million) By Region

Figure 15: Global Monofilament Polyamide Suture Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Monofilament Polyamide Suture Market Value (USD Million) By Region

Figure 23: Global Monofilament Polyamide Suture Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

89 items

Table 1: Market Segmentation Analysis

Table 2: Global Monofilament Polyamide Suture Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Monofilament Polyamide Suture Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Monofilament Polyamide Suture Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Monofilament Polyamide Suture Market Value (USD Million) By Region

Table 10: Global Monofilament Polyamide Suture Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Monofilament Polyamide Suture Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Monofilament Polyamide Suture Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Monofilament Polyamide Suture Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Johnson & Johnson Basic Information And Sales Area

Table 31: Johnson & Johnson. Products Portfolio

Table 32: Medtronic Basic Information And Sales Area

Table 33: Medtronic. Products Portfolio

Table 34: B. Braun Basic Information And Sales Area

Table 35: B. Braun. Products Portfolio

Table 36: Corza Medical Basic Information And Sales Area

Table 37: Corza Medical. Products Portfolio

Table 38: Demetech Corporation Basic Information And Sales Area

Table 39: Demetech Corporation. Products Portfolio

Table 40: Unimed Basic Information And Sales Area

Table 41: Unimed. Products Portfolio

Table 42: Covidien Basic Information And Sales Area

Table 43: Covidien. Products Portfolio

Table 44: Hu-Friedy Mfg Basic Information And Sales Area

Table 45: Hu-Friedy Mfg. Products Portfolio

Table 46: Peters Surgical Basic Information And Sales Area

Table 47: Peters Surgical. Products Portfolio

Table 48: DemeTech Basic Information And Sales Area

Table 49: DemeTech. Products Portfolio

Table 50: Kono Manufacturing Basic Information And Sales Area

Table 51: Kono Manufacturing. Products Portfolio

Table 52: Dolphin Basic Information And Sales Area

Table 53: Dolphin. Products Portfolio

Table 54: Assut Medical Sarl Basic Information And Sales Area

Table 55: Assut Medical Sarl. Products Portfolio

Table 56: Teleflex Basic Information And Sales Area

Table 57: Teleflex. Products Portfolio

Table 58: Lotus Surgicals Basic Information And Sales Area

Table 59: Lotus Surgicals. Products Portfolio

Table 60: Luxsutures Basic Information And Sales Area

Table 61: Luxsutures. Products Portfolio

Table 62: Advanced MedTech Solutions Basic Information And Sales Area

Table 63: Advanced MedTech Solutions. Products Portfolio

Table 64: SERAG-WIESSNER Basic Information And Sales Area

Table 65: SERAG-WIESSNER. Products Portfolio

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Market Value (USD Million) (2025-2032) By Types

Table 69: Global Market Share (%) By Types (2032)

Table 70: Global Monofilament Polyamide Suture Market Value (USD Million) By Region

Table 71: Global Monofilament Polyamide Suture Market Share (%) By Region (2025-2032)

Table 72: North America Market Value (USD Million) (2025-2032) By Country

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: North America Market Value (USD Million) (2025-2032) By Types

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Europe Market Value (USD Million) (2025-2032) By Types

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 81: South America Market Value (USD Million) (2025-2032) By Country

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: South America Market Value (USD Million) (2025-2032) By Types

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 87: Research Programs/Design For This Report

Table 88: Key Data Information From Secondary Sources

Table 89: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Monofilament Polyamide Suture Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Medtronic; B. Braun; Corza Medical; Demetech Corporation; Unimed; Covidien; Hu-Friedy Mfg; Peters Surgical; DemeTech; Kono Manufacturing; Dolphin; Assut Medical Sarl; Teleflex; Lotus Surgicals; Luxsutures; Advanced MedTech Solutions; SERAG-WIESSNER
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Intense competition among key players is triggering price wars, compressing profit margins. Companies must balance innovation with cost efficiency to maintain market share.

Market Segmentation

Loading chart…

Monofilament Polyamide Suture Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Colorless Polyamide Suture

Dyeing Polyamide Suture

Regional Insights

Loading chart…

Key Regional Drivers5 items

North America: Advanced healthcare infrastructure, high R&D spending, aging demographics

Europe: EU regulatory compliance, high surgeon expertise, mature MIVS adoption

Asia Pacific: Urbanization, government healthcare reforms, rising middle-class disposable income

Latin America: Public-private healthcare collaborations, growing surgical volumes

Middle East & Africa: Private-sector infrastructure investments, medical tourism growth

Competitive Landscape

Johnson & Johnson: Expansion in emerging markets via surgical equipment bundling

Medtronic: R&D investment in absorbable polyamide variants for orthopedic applications

B. Braun: Vertical integration to stabilize raw material procurement costs

Corza Medical: OEM partnerships for specialty sutures in reconstructive surgery

Teleflex: Premium pricing tied to proprietary anti-microbial coating technology

Demetech Corporation: Local manufacturing in Asia-Pacific for cost-sensitive clients

Key Monofilament Polyamide Suture Companies18 items

Johnson & Johnson

Medtronic

B. Braun

Corza Medical

Demetech Corporation

Unimed

Covidien

Hu-Friedy Mfg

Peters Surgical

DemeTech

Kono Manufacturing

Dolphin

Assut Medical Sarl

Teleflex

Lotus Surgicals

Luxsutures

Advanced MedTech Solutions

SERAG-WIESSNER

Market Ecosystem

Raw material suppliers — supply nylon 6/6 polymer and additives for filament production

Technology providers — license extrusion and coating equipment for suture manufacturing

OEM manufacturers — produce monofilament sutures via specialized polymer processing

Distributors — manage logistics to hospitals, clinics, and surgical centers

Regulators — enforce compliance with ISO 13485 and FDA Class II medical device standards

End users — hospitals and ambulatory surgical centers using sutures for wound closure

Service providers — offer sterilization, packaging, and post-market surveillance solutions

Recent Industry Insights

Analyst Overview

Table of Contents